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Abstract
Background: Multinucleated giant cells have been noticed in diverse arthritic conditions since their first description
in rheumatoid synovium. However, their role in the pathogenesis of osteoarthritis (OA) or rheumatoid arthritis (RA)
still remains broadly unknown. We aimed to study the presence and characteristics of multinucleated giant cells
(MGC) both in synovium and in subchondral bone tissues of patients with OA or RA.
Methods: Knee synovial and subchondral bone samples were from age-matched patients undergoing total joint
replacement for OA or RA, or non-arthritic post mortem (PM) controls. OA synovium was stratified by histological
inflammation grade using index tissue sections. Synovitis was assessed by Krenn score. Histological studies
employed specific antibodies against macrophage markers or cathepsin K, or TRAP enzymatic assay.
Results: Inflamed OA and RA synovia displayed more multinucleated giant cells than did non-inflamed OA and
PM synovia. There was a significant association between MGC numbers and synovitis severity. A TRAP negative/
cathepsin K negative Langhans-like subtype was predominant in OA, whereas both Langhans-like and TRAP-positive/
cathepsin K-negative foreign-body-like subtypes were most commonly detected in RA. Plasma-like and foam-like
subtypes also were observed in OA and RA synovia, and the latter was found surrounding adipocytes. TRAP positive/
cathepsin K positive osteoclasts were only identified adjacent to subchondral bone surfaces. TRAP positive osteoclasts
were significantly increased in subchondral bone in OA and RA compared to PM controls.
Conclusions: Multinucleated giant cells are associated with synovitis severity, and subchondral osteoclast numbers are
increased in OA, as well as in RA. Further research targeting multinucleated giant cells is warranted to elucidate their
contributions to the symptoms and joint damage associated with arthritis.
Background
Osteoarthritis (OA) is a chronic disease affecting the
whole joint with progressive changes in the articular car-
tilage. Changes also in the synovium and subchondral
bone are closely associated with symptoms [1], and are
thought to contribute to cartilage damage [2]. Rheumatoid
arthritis (RA) is characterized by inflammation in the
synovium, and also in subchondral bone [3].
Synovitis in RA drives pain, cartilage degradation and
pannus formation with subsequent erosions. It is in-
creasingly recognized that synovitis is also observed both
in early and in late OA [4]. Indeed, synovitis predicts
structural severity and progression of tibiofemoral cartil-
age damage in OA [5]. Histological features of OA syno-
vitis include synovial lining hyperplasia, infiltration of
macrophages and lymphocytes, angiogenesis and fibrosis
[6]. OA synovitis may sometimes resemble that which is
characteristic of RA. Subchondral inflammation might
also contribute to increased bone turnover and joint
damage in both OA and RA [7]. Although OA and RA
differ in their aetiologies, with mechanical factors being
key to knee OA progression and specific immunity driv-
ing RA, common mechanisms may contribute to joint
damage and pain in both conditions.
Macrophage infiltration is a characteristic feature of
synovitis, and is associated with radiographic joint dam-
age both in OA [6] and in RA [8]. Macrophages can fuse
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to form multinucleated giant cells (MGCs) and this
represents a cellular specialization for improved phago-
cytosis [9]. Although these macrophage polykaryons,
generally classified into Langhans (LGC) and foreign
body giant cells (FBGC), resemble osteoclasts morpho-
logically, they differ in their functional role. FBGC de-
rived from tissue surrounding total joint arthroplasties
were found to express tartrate-resistant acid phosphatase
(TRAP) [10]. In fact, many osteoclasts markers, such as
TRAP, cathepsin K or metalloproteinase (MMP)−9,
among others, can also be expressed by both FBGC and
LGC at low levels [11]. In addition, the expression of
specific chemokines such as chemokine (C-C motif ) lig-
and (CCL)−2,−3,−4,−5 and−9 have been found to be
highly expressed by FBGCs in comparison to osteoclasts
[12]. However, whereas osteoclasts are capable of form-
ing lacunar pits of resorption in bone, LGC and FBGC
are not [13].
The formation of giant cells in non-skeletal tissues can
arise as a result of chronic inflammation due to the pres-
ence of foreign material or persistent pathogens. The
physiological role of MGCs includes remodelling of
granuloma-associated extracellular matrix and clearance
of foreign particles from tissues [14]. In vitro studies of
human tuberculous granulomas have shown a phago-
cytic activity of LGCs in the presence of low virulence
mycobacterium whereas these cells were incapable of
phagocytosis in the presence of highly virulent mycobac-
teria, despite still retaining a strong antigen presentation
capability [15]. FBGC together with their macrophage
precursors adhere to different synthetic surfaces and de-
grade or resorb particles that are too large to permit
macrophage phagocytosis [16]. Another MGC subtype,
foam-like (sometimes called Touton cells), is character-
ized by lipid uptake [17].
MGCs have been described in inflammatory infiltrates
in RA [18], but have also been noticed in the synovium
of other arthritic conditions, such as tuberculous arth-
ritis, traumatic arthritis, villonodular synovitis [19], an-
kylosing spondylitis, psoriasis and OA [20]. Despite the
first description of synovial giant cells in RA by Grimley
and Sokoloff in 1966 [21], their role in the pathogenesis
of OA remains largely unknown. Some recent reports
described the presence of these cells in OA synovium
[22, 23], whereas others report few or none [24, 25].
Subchondral bone turnover is increased in OA, as
evidenced by bone formation and resorption biomarkers
[26], as well as by imaging techniques, including
radiography [27], computerized tomography, magnetic
resonance imaging [28], dual X-ray absorptiometry and
scintigraphy [29]. Indeed, recent data from animal models
suggest that subchondral bone remodelling might precede
and mediate cartilage damage in OA [30], and treatments
that target osteoclasts might reduce OA pain [31].
Although activated osteoclasts might be involved in the
pathogenesis of OA and RA [32, 33], their relative abun-
dance in the subchondral bone of these diseases remains
unknown.
In this study we aimed to study the presence of MGCs
in both synovium and subchondral bone tissues of
patients with OA and further characterize their phe-
notypes. We also investigated their relationship with
synovial inflammation, and compared our findings with
MGCs seen in RA.
Methods
Patients
An age and sex matched cross-sectional comparative
study was performed on knee samples from people with
RA (n = 21) or OA (n = 42) purposively selected from
the Arthritis Research UK Pain Centre Joint Tissue
Repository. Informed consent was gained from each
donor (for PM cases, next of kin) according to protocols
approved by the United Kingdom National Research
Ethics Service (Nottingham Research Ethics Committee
1 (05/Q2403/24) and Derby Research Ethics Committee
1 (11/H0405/2)).
All participants in the OA and RA groups satisfied
ACR classification criteria for knee OA [34] or RA [35].
RA samples were from consecutive cases collected at
joint replacement surgery. Patients with RA were cli-
nically examined prior to joint replacement surgery, a
28-joint Disease Activity Score (DAS28) calculated, and
disease activity was classified as high, moderate or low
according to European League Against Rheumatism cri-
teria [36]. In order to explore possible associations with
synovitis, OA samples, also collected at joint replace-
ment surgery, were purposively selected according to
brief histological grading of the severity of synovitis, as
previously described [37], and allocated into 2 groups;
non-inflamed OA (OANI; n = 21) without lining hyper-
plasia or increased cellularity (grade 0 and 1), or in-
flamed OA (OAI, n = 21) with lining cell hyperplasia and
marked hypercellularity (grade 3). The latter group rep-
resented 28 % from the screened OA total knee replace-
ment samples. In order to compare MGC phenotypic
characteristics between OA and RA, and for correlation
analyses, OANI and OAI samples were combined to give
single OA group. Non-arthritic post-mortem (PM) cases
were used as controls (n = 21). PM cases were selected
as non-arthritic if there was no reported arthropathy on
case note review, and relatives were unaware of the
deceased reporting knee pain during the past year, and
no Heberden’s nodes or knee joint osteophytes were
observed on macroscopic examination post mortem. OA
and PM cases were age matched to RA cases by screen-
ing consecutive eligible cases for each disease group
aged within 2 years of each index RA case.
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Synovium and mid-coronal fragments of medial tibial
plateaux were collected from selected patients and used
for enzymatic histochemistry and immunohistochemistry.
Samples were obtained, formalin-fixed, decalcified in 10 %
ethylenediaminetetraacetic acid (tibial plateaux only) and
paraffin embedded at Sherwood Forest Hospitals NHS
Foundation Trust, Sutton in Ashfield, UK.
Histopathology
All histological assessments were undertaken by a single
researcher (IP-P) who was blinded to diagnostic group.
Synovitis severity was firstly graded according to
Haywood et al., 2003, as criteria for inclusion of patients
in both OANI and OAI groups. This score, mainly based
in lining hyperplasia grading, was complemented by
using the Krenn score which provides more detailed
characterization of synovial inflammation using haema-
toxylin and eosin stained sections, as previously de-
scribed in both OA and RA [38]. Briefly, in addition to
lining hyperplasia, fibrovascular alterations in the inter-
stitium and cellular infiltration were evaluated using 0–3
point subscales, where 0 indicates absence, 1 mild, 2
intermediate and 3 strong. The total score was obtained
from the sum of partial grades with a maximum total
score of nine. Spearman’s rank correlation coefficients
were used to explore association between the two
methods for scoring synovitis in OA.
Synovial MGCs were identified as large cells showing
three or more nuclei inside their cytoplasm in haema-
toxylin and eosin stained sections, thereby avoiding con-
founding by mitotic cells with two nuclei. Classification
of different morphological variants was performed ac-
cording to the arrangement and composition of their
organelles. Foreign body giant cells were identified as
MGCs with many nuclei diffusely distributed throughout
the cytoplasm [16]. Langhans giant cells, in contrast,
were recognized by the multiple nuclei arranged in a
horseshoe shape [9]. Multinucleated foam giant cells
were characterized by numerous nuclei clustered to-
gether, surrounded by a foamy cytoplasm [17]. Although
multinucleated plasma cells are not derived from macro-
phage lineage, we also assessed these subtype of MGCs
by their eccentric nuclei with a dense distribution of
chromatin [39]. Osteoclasts were sought in synovium as
TRAP-positive MGCs, and also identified in subchon-
dral bone as TRAP-positive MGCs adjacent to bone or
calcified cartilage.
Sections were analyzed through 10× and 40× objective
lenses to identify MGC location within the lining and
sublining layers and to assess cell morphology, respect-
ively. An image of each MGC was captured using a 40×
objective (AxioCam, Carl Zeiss Ltd., North Ryde, NSW,
Australia) and maximum diameter (μm) was measured
with AxioVision Rel 4.8 software (Carl Zeiss Ltd.,
Welwyn Garden City, UK). Sections of synovium were
scanned with EPSON Expression XL 10000 scanner
(Epson America Inc, Long beach, CA, USA) for measur-
ing the synovial biopsy area with AxioVision Rel 4.8 soft-
ware (Carl Zeiss Ltd., Welwyn Garden City, UK). MGC
densities are expressed as number per mm2.
TRAP enzymatic activity assay and immunohistochemistry
Synovial and tibial plateaux samples were serially sec-
tioned at 5 μm, dewaxed, rehydrated and incubated
overnight in 1 mM CaCl2 and 1 mM MgCl2, then stained
for TRAP, according to manufacturer’s protocol (Sigma,
St Louis, Mo, USA). Mid-coronal fragments of medial tib-
ial plateaux were divided into three equal parts (external,
central and internal) and TRAP positive cells with mul-
tiple nuclei were counted in each part as positive MGCs
under light Axioskop-50 microscope (Carl Zeiss Ltd.,
Welwyn Garden City, UK), using a 40× objective lens.
Total osteoclastic activity was expressed as the sum of
TRAP positive cells of each part per mm2.
Macrophages were visualized using mouse monoclonal
anti-CD68 primary antibody, 1 mg/ml at a 1/200 dilu-
tion (Dako, clone PG-M1, M0876, Golstrup, Denmark)
and a nickel-enhanced ABC-peroxidase technique [40]
(Vector laboratories, CA, USA). Cathepsin K positive
cells were visualized with a mouse monoclonal anti-
cathepsin K (Abcam, ab66237, Cambridge, UK) antibody,
0,5 mg/ml at a 1/100 dilution, and ABC-peroxidase de-
veloped with diaminobenzidine. Horse anti-mouse IgG
secondary antibodies, 0,5 mg/ml (Vector laboratories,
BA2001, CA, USA), were used at dilutions 1/100 for
CD68 and 1/4000 for cathepsin K. Antigen retrievals used
were 1 mg/ml pepsin in 0.5 M acetic acid, 2 h at 37 °C for
CD68, and 10 mM citrate buffer, pH 6, 30 min at 85 °C
for cathepsin K. Sections were counterstained with eosin
for CD68 and with haematoxylin for cathepsin K; and
mounted with di-n-butylphthalate in xylene (DPX mount-
ing medium, VWR International Ltd., Lutterworth, UK).
Statistical analysis
All statistical analyses were performed using SPSS version
17.0 software for Windows (IBM, New York, NY, USA).
Descriptive data are expressed as the median ± interquartile
range (IQR). Proportions were compared using Chi-
squared test. Associations are expressed using Spearman’s
rho correlation coefficient. Comparisons between multiple
groups used Kruskal-Wallis tests with Bonferroni correc-
tion of post hoc Mann–Whitney U tests. P < 0.05 was con-
sidered significant.
Results
Demographic and clinical details
Table 1 shows the demographic and clinical characteris-
tics of participants. Age matching was successful, and
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there were no significant gender differences between
groups. Glucocorticoids had been received by six partici-
pants (3 PM and 3 RA), and bisphosphonates by 2 RA,
one also receiving calcium and vitamin D supplementa-
tion. Non-steroidal anti-inflammatory drugs were used
in analgesic doses by 16 participants (6 OANI, 4 OAI
and 6 RA). Disease modifying anti-rheumatic drugs
(DMARDs) were used by 17 participants with RA (11
patients were using methotrexate, 5 sulphasalazine and 1
ciclosporin A). Five patients used a combination of 2
DMARDs, including hydroxychloroquine, rituximab or
etanercept). DAS28 score showed five patients with high
disease activity, eight with moderate and eight with low
activity.
Characterization of synovial MGC in OA and RA
The percentage of patients who displayed MGCs in sy-
novia was higher in RA and OAI when compared with
OANI and PM (p < 0.01, Fig. 1a). MGCs were observed
in more OAI than OANI synovia, p = 0.006, both in
lining and sublining synovial layers. Absolute MGC
number adjusted for synovial section area (median
(IQR)) was significantly lower in OA (0 (0–0.06) per
mm2) than in RA (0.10 (0.01–0.22) per mm2, p = 0.001).
In OA synovia, MGCs were smaller than those observed
in RA (Fig. 1b). The full range of different MGC
subtypes identified by their nuclear organization was
observed in each disease (Fig. 2). However, whereas
Langhans-like MGCs were the most abundant subtype
in OA (Fig. 1c), foreign body-like, in addition to
Langhans-like MGCs, were prominent in RA synovia
(Fig. 1d). Foam-like and plasma-like MGCs were less
abundant in both disease groups. Foam-like MGCs were
identified near to and surrounding fat cells in inflamed
synovia from patients with either OA or RA. Furthermore,
Table 1 Demographic and clinical details
PM OANI OAI RA
N 21 21 21 21
Age, years 68 (63–73) 68 (63–72) 68 (63–72) 68 (63–72)
Gender, female, % 43 48 38 50
ESR, mm/hr Not available 7 (5–13) 14 (7–22) 22(13–34)*
Serum CRP, mg/L Not available 5(2–5) 5(5–6) 12(5–47)*#
DAS28 − − − 3,5 (2,4–4,8)
Data were available for erythrocyte sedimentation rate (ESR) on 13 non-inflamed
OA (OANI), 18 inflamed OA (OAI) and 20 rheumatoid arthritis (RA) cases; and for
serum C-reactive protein (CRP) on 12 OANI, 18 OAI and 21 RA cases. DAS28; 28
joint Disease Activity Score. Values represent medians and IQR. *p < 0.01 vs. OANI;
#p < 0.01 vs. OAI
Fig. 1 Characterization of MGC subtypes in OA and in RA. a. A greater proportion of inflamed OA (OAI) and RA cases displayed MGCs than did
non-inflamed OA (OANI) or non-arthritic (post mortem, PM) controls. b. Increased MGC size in RA compared with OA cases. c and d. Relative
abundance of morphological MGC subtypes observed in OA (c) and RA (d) synovia. Bars in b-d represent medians, with IQRs indicating between
MGC heterogeneity
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multiple mononuclear CD68 positive cells were found in a
crown-like structure encircling adipocyte cells (Additional
file 1).
We also analyzed TRAP activity and Cathepsin K im-
munoreactivity as markers of MGCs in synovium [41].
We found that most of the foreign body-like MGCs
positively stained for TRAP, whereas many MGCs
displaying characteristics of Langhans, multinucleated
foam-like and plasma cells were TRAP negative (Figs. 3a
and b). Cathepsin K-immunoreactive MGCs were only
localized to synovial pannus adjacent to bone surfaces in
RA tibial plateau (Fig. 3c), and were not observed in syn-
ovial tissue distant from bone or cartilage. Some mono-
nuclear synovial lining and sublining cells also stained
positive for cathepsin K, both in OAI and in RA synovia
(Figs. 3d and e).
Synovial inflammation in OA and RA
Haywood synovitis score was significantly correlated with
Krenn score in patients with OA (r = 0791; p < 0001). OAI
and RA samples were each characterized by synovial
lining hyperplasia, sublining fibrosis and stromal vas-
cularization, along with inflammatory infiltrates often con-
taining follicle-like lymphoid aggregates (Figs. 4a-d). OAI
and RA synovia had higher synovitis grades than OANI
and PM (each p < 0.001, Fig. 4e). Scores for each Krenn
subscale (stromal cell density, lining hyperplasia and in-
flammatory infiltrate) were increased in OAI and RA
synovia in comparison with OANI and PM (each p < 0.05).
Synovitis grade and synovial MGC density were sig-
nificantly associated, both in OA and RA groups (Fig. 4f ).
Furthermore, MGC densities were higher in cases with
greater inflammatory infiltration in OA (r = 0.63; p = 0.03),
and with higher stromal cellularity in RA (r = 0.53; p =
0.03). Associations between serum CRP levels and MGC
density did not reach statistical significance in either OA
or RA (r = 0.30; p = 0.38 and r = 0.09; p = 0.75 res-
pectively). Likewise, serum ESR was not significantly asso-
ciated with MGC density in OA or RA (r = −0.20; p = 0.55
and r = −0.12; p = 0.68, respectively).
Subchondral bone osteoclasts in OA and RA
We then analyzed the presence of multinucleated cells in
subchondral bone of medial tibial plateaux. MGCs adja-
cent to bone surfaces that displayed TRAP activity and a
random nuclear organization were counted as osteoclasts.
Increased numbers of TRAP-positive osteoclasts were ob-
served in subchondral bone from people with RA, or with
OA and either non inflamed or inflamed synovium
(Figs. 5b-d) compared with non-arthritic PM controls, P <
0.05 in all comparisons (Fig. 5a). No significant differences
in osteoclast numbers were found between OAI and RA
groups, whereas TRAP-positive subchondral osteoclasts
were more abundant in RA compared to the non-
inflamed OA group, p = 0.036 (Fig. 5e). Associations
between subchondral TRAP-positive osteoclasts and syn-
ovial MGC numbers were not statistically significant in
either OA (r = 0.30, P = 0.62) or RA (r = −0.14; P = 0.76).
Fig. 2 Morphological characterization of synovial MGC subtypes in OA and in RA. Foreign body giant cells were identified as MGCs with many
nuclei diffusely distributed throughout the cytoplasm (a). Langhans giant cells were recognized by the multiple nuclei arranged in a horseshoe
shape (b). Foam MGC subtype was characterized by numerous nuclei clustered together, surrounded by a foamy cytoplasm (c). Plasma MGC
subtype was assessed by their eccentric nuclei with a dense distribution of chromatin (d). Overall MGC subtypes were identified in either OA or
RA. Arrows indicate each different MGC subtype in synovium. Haematoxylin and eosin staining. Scale bars = 20 μm
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Discussion
In this study we have shown that MGCs were increased
in OA, especially in inflamed synovia which presented
similar MGC numbers to those observed in RA. MGC
subtypes might differ between OA and RA, with a rela-
tive sparsity of foreign body MGCs in OA. In addition,
we provide histopathological evidence of increased sub-
chondral osteoclastic activity in OA, as well as in RA.
Together, our findings indicate a clear activation of
mononuclear phagocyte system cells, both in synovium
and in subchondral bone, and both in OA and in RA.
Synovial inflammation is a common feature of OA, al-
though the intensity and nature of inflammation may
differ between OA and RA [42]. It is currently unknown
whether synovitis characterizes a subgroup of people
with OA, or may occur during phases of the disease in
all patients. In cross sectional studies, the extent of
synovitis varies between cases, ranging from normal to
severe inflammation [43]. Cases purposively selected
for the current study represented both ends of this
spectrum in order to explore associations between
MGCs and synovitis, and to characterize MGCs in de-
tail. The inflamed OA group studied here, comprised
28 % of consecutive cases donating tissue at joint re-
placement surgery for OA, and therefore represents a
common inflammatory phenotype amongst people with
end stage OA. A similar prevalence of synovitis was ob-
served in a previous study of 104 participants undergo-
ing joint replacement surgery for knee OA [37].
We have also demonstrated that there is a prevalent
subgroup of people with OA in whom the numbers of
MGCs are comparable to those in people with RA at the
time of joint replacement surgery. Furthermore, MGC
densities were significantly associated with the total
synovitis score indicating that this is a cellular charac-
teristic of synovitis that is shared between OA and RA,
suggesting shared inflammatory mechanisms. Varying
estimates of the prevalence of MGCs in synovium from
people with OA or RA might reflect the degree of syno-
vitis in cases selected for study.
In the current study, statistically significant associa-
tions were not detected between ESR or serum CRP and
Fig. 3 TRAP and cathepsin K enzyme activity in synovium from OA and RA patients. a and b. Representative synovial TRAP-positive and TRAP-negative
MGCs both in inflamed OAI (a) and RA (b) cases. c. Cathepsin K-immunoreactive MGC localized to synovial pannus adjacent to bone surface in RA and
OA tibial plateaux. d and e. Cathepsin K-immunoreactive mononuclear synovial lining (d) and sublining (e) cells in OAI and in RA synovium. Filled
arrows indicate TRAP-positive or cathepsin K-positive cells. Open arrows indicate TRAP-negative MGCs. P = pannus and B = bone, scale bars = 50 μm
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MGC numbers, suggesting local co-ordination of MGCs
and inflammation within the synovium. However, larger
populations would need to be investigated to explore
smaller possible systemic influences on MGC formation.
A limitation of cross sectional studies such as ours is
that differences between groups may be caused by un-
measured confounding factors. We have attempted to
minimize possible confounding by carefully matching
cases by gender and age and although our assessments
were undertaken blinded to diagnostic group, we cannot
be certain that detection of differences between groups
was entirely free from observer bias. Participants with
RA were more likely to be using glucocorticoids, bispho-
sphonates or DMARDs than were those with OA, and
inhibition of MGCs by anti-inflammatory drugs might
have led us to underestimate the magnitude of increased
MGC and osteoclast numbers in RA.
Our data extend those from a previous study showing
two main types of giant cells in arthritic synovium [44].
We have demonstrated that OA and RA synovia exhibit
distinct patterns of MGC subtype frequency, Langhans-
like MGC being the predominant subtype in people with
OA. Langhans-like MGCs contribute to processing and
presentation of antigens and the development of specific
immune responses, and their presence in OA might indi-
cate a contribution of specific immunity to OA [45–47].
The pathological relevance of smaller MGC size and lower
prevalence of foreign body like giant cells in OA than in
RA remains unclear, but we speculate that deficiencies in
processing cartilage degradation products might con-
tribute to synovitis in OA.
In addition to the main Langhans and foreign-body
MGC subtypes, we also observed foam-like MGCs in
synovia from people undergoing joint replacement
Fig. 4 Synovial inflammation in OA and RA. a-d. Representative sections of synovia from cases with median Krenn scores for each disease group
stained with haematoxylin and eosin. Panels represent post-mortem, PM (a), non-inflamed OA, OANI (b), inflamed OA, OAI (c) and RA (d) cases.
Scale bars = 100 μm. e. Synovitis, determined as total Krenn score was greatest in OAI and RA cases. f. Numbers of MGCs per area of synovium
were positively correlated with synovitis scores both in OA and in RA cases
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surgery for either OA or RA. Previous studies have most
frequently localized foam-like MGCs in lesions contain-
ing cholesterol and lipid deposits, such as xanthomas or
xanthogranulomas [48], and these MGCs might develop
when a cell fusion stimulus is also accompanied by a fac-
tor stimulating lipid uptake [49]. The contribution of
foam-like MGCs to synovitis in OA and RA deserves
further study, given recognized associations between hu-
man arthritis, obesity and metabolic syndrome [50], and
preclinical evidence that synovial foam-like MGCs might
be associated with increased bone resorption [51].
We found that foreign body-like MGCs positively
stained for TRAP, indicating that these cells might have
osteoclastic activity [52], whereas Langhans MGCs
were negative for TRAP. Absence of TRAP activity in
Langhans MGCs has also been noted in canine and fe-
line neoplasia [53]. Cathepsin K was not a specific
marker of MGC in inflamed synovium, where it was also
localized to mononuclear cells more distant from bone
and cartilage. We did not identify cathepsin K activity in
MGCs that were distant from bone or cartilage in human
synovia, in contrast to previous suggestions that cathepsin
K-positive staining might be a general feature of MGCs
[41]. Cathepsin K-negative MGCs have also been reported
in human breast carcinoma and lung biopsies [54]. Our
findings suggest that cathepsin K-immunoreative MGCs
in human synovium might represent an osteoclastic MGC
subtype. However, we cannot be certain whether TRAP
and cathepsin K positive MGCs detected in the synovium
were osteoclasts, or alternatively osteoclast precursors.
Diverse MGC subtypes have been described previously in
various autoimmune, infectious or sarcoid granulomatous
diseases. The demonstration of diverse morphological
subtypes [14], distribution and immunohistochemical cha-
racteristics [55] might reflect discrete functional states of
MGCs.
TRAP and cathepsin K positive osteoclasts were local-
ised adjacent to bone and cartilage, both in synovium
Fig. 5 Subchondral bone TRAP positive osteoclast in OA and in RA. a-d. Representative sections from non-arthritic patients (a), with OANI (b), OAI
(c) and RA (d) showing TRAP positive osteoclasts adjacent to bone surfaces. Scale bars = 20 μm. e. c. Absolute TRAP-positive osteoclast number
adjusted for the area of mid-coronal tibial plateau fragments. Bars represent medians with IQRs
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and in subchondral bone. The formation of resorption
subchondral pits by osteoclasts [56] and cells that resorb
mineralized and unmineralized articular cartilage [57]
contribute to hard tissue remodeling in OA. Increased
subchondral bone turnover and resorption might con-
tribute to OA development, and might be features of
both early and end stage disease [58]. Our findings sug-
gest a contribution of increased osteoclast activation to
increased subchondral bone remodelling both in RA and
in OA. Increased numbers of TRAP-positive MGCs in
OA subchondral bone reflect augmented osteoclastic
activity in animal models of OA [59], and our findings
suggest similarly increased subchondral osteoclastic
activity in human knee OA. Future studies should ex-
plore possible associations between subchondral osteo-
clast numbers and biochemical or imaging markers of
subchondral bone turnover. Subchondral osteoclast
numbers were increased in both inflamed and non-
inflamed OA subgroups, whereas synovial MGCs were
more frequently observed in the inflamed subgroup and
were associated with synovitis grade. Furthermore, no
statistically significant association was found between
the increased numbers of subchondral osteoclasts and
synovial MGCs. These data lead us to suggest that syn-
ovial inflammation and subchondral bone remodelling
each may be regulated by different mediators.
Conclusion
We found that MGCs were increased in OA, especially
in inflamed OA which presented similar MGC numbers
to those observed in RA. Synovial MGCs displayed a
range of morphological subtypes, with Langhans giant
cells being the predominant variant in OA, and both
Langhans and foreign body like subtypes in RA. MGCs
might contribute to catabolic activity and be regulated
by local factors within the synovium, whereas MGCs in
subchondral bone might predominantly represent osteo-
clasts and be regulated by factors that are independent
of synovitis. Preclinical studies and early clinical trials
support the targeting of osteoclasts in the treatment of
OA [31]. Further research is required to determine the
potential of targeting MGCs to improve pain and joint
damage both in OA and in RA.
Additional file
Additional file 1: Morphological MGC foam subtype and CD68
positive cells surrounding fat cells in OA and in RA. A and B. MGCs
displaying a foam-like subtype were identified near to and surrounding
fat cells in inflamed synovia from patients with either OA (A) or RA (B).
Haematoxylin and eosin staining. Scale bar = 20 μm. Open arrows indicate
foam-like MGC and A = adipocyte. C and D. Multiple mononuclear CD68
positive cells were found in a crown-like structure encircling adipocyte cells
in both OA (C) and RA (D). Immunohistochemistry for CD68, using eosin
contrast. Scale bar = 100 μm. (TIFF 3238 kb)
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